Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

by palligoelme@gmail.com | Aug 8, 2025 | Clinical Trials

​ Conditions: Lacunar Stroke; Stroke; Ischemic Stroke Interventions: Drug: rt-PA; Drug: DAPT Sponsors: Nippon Medical School; Japan Research Foundation for Clinical Pharmacology; Takeda Science Foundation – Medical Research Grant Not yet recruiting Conditions:...

A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

by palligoelme@gmail.com | Aug 8, 2025 | Clinical Trials

​ Conditions: Influenza Interventions: Drug: Suraxavir Marboxil; Drug: Oseltamivir Sponsors: Jiangxi Kerui Pharmaceutical Co., Ltd Not yet recruiting Conditions: Influenza Interventions: Drug: Suraxavir Marboxil; Drug: Oseltamivir Sponsors: Jiangxi Kerui...

Pressure-Volume Loop Assessment in Valvular Heart Disease

by palligoelme@gmail.com | Aug 8, 2025 | Clinical Trials

​ Conditions: Heart Failure; Structural Heart Disease; Interventional Cardiology Interventions: Other: Observational Invasive Hemodynamic Assessment Sponsors: Nantes University Hospital; Fédération Française de Cardiologie Not yet recruiting Conditions: Heart Failure;...

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

by palligoelme@gmail.com | Aug 8, 2025 | Clinical Trials

​ Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis (LN); Systemic Sclerosis (SSc); Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome (APS) Interventions: Drug: YTS109 cell Sponsors: China...

Avatar Therapy in Virtual Reality for Treatment-Resistant Major Depressive Disorder: A Pilot Study

by palligoelme@gmail.com | Aug 8, 2025 | Clinical Trials

​ Conditions: Treatment-Resistant Major Depressive Disorder Interventions: Other: Avatar Therapy Sponsors: Ciusss de L’Est de l’Île de Montréal Active, not recruiting Conditions: Treatment-Resistant Major Depressive Disorder Interventions: Other: Avatar...